These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
The Subject Expert Committee has recommended grant of permission to conduct Phase 3 trials under certain conditions
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
It plans to deliver over 300 million doses to the Indian government
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19
In his new role as Managing Director India and Global Head, Partnerships and Innovative Finance, Singh will oversee the financial, human, and operational functions of the India office
The company will provide the technical and financial resources to support the study
Subscribe To Our Newsletter & Stay Updated
